These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 13729010)

  • 1. [Studies on the mechanism of heparin action on blood clotting and fibrinolysis].
    NIEWIAROWSKI S; WEGRZYNOWICZ Z
    Pol Tyg Lek; 1961 Jun; 16():901-5. PubMed ID: 13729010
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the mechanism of action of nicotinic acid on blood coagulation and fibrinolysis].
    SAILER S
    Wien Z Inn Med; 1960 Aug; 41():307-16. PubMed ID: 13745428
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of plasmin on the blood coagulation system; history of investigations on fibrinolysis].
    NIEWIAROWSKI S
    Postepy Hig Med Dosw; 1959; 13():225-64. PubMed ID: 14427145
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the effect of magnesium sulfate on the level of lipids and on the indices of coagulation and fibrinolysis in atherosclerotic patients].
    ALEKSANDROW D; CISWICKA-SZNAJDERMAN M; GAJEWSKI J; IGNA TOWSKA H; SZNA JDERMAN M; WOCIAL B
    Pol Arch Med Wewn; 1960; 30():1045-53. PubMed ID: 13682250
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blood clotting system and fibrinolysis in swine during extracorporeal perfusion of heterogenic liver].
    Lukasiewicz H; Rosnowska M; Polański J; Rowiński W; Olszewski W
    Pol Przegl Chir; 1970 Aug; 42(8):1202-5. PubMed ID: 5472521
    [No Abstract]   [Full Text] [Related]  

  • 6. The effect of long term feeding of essential fatty acids on blood coagulation and fibrinolysis.
    PEYMAN MA; NITZBERG SI; GOLDSTEIN R; NOTHMAN M; PROGER S
    Am J Med; 1960 Jun; 28():884-94. PubMed ID: 14432470
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical experience with trypsin-heparin mixture with fibrinolytic action].
    SCARDIGLI G; GUIDI G; LOMBARDI V
    Minerva Med; 1961 Feb; 52():416-21. PubMed ID: 13747075
    [No Abstract]   [Full Text] [Related]  

  • 8. [The test of heparin tolerance "in vitro"].
    FORTEZA BOVER G; PERIS MORA R; TORMO ALFONSO V; ALGARRA VIDAL F
    Rev Clin Esp; 1960 Oct; 79():38-44. PubMed ID: 13700898
    [No Abstract]   [Full Text] [Related]  

  • 9. Hemostatic- and fibrinolytic-affecting agents in experimental vascular sensitization.
    COHEN SG; SAPP TM
    Circ Res; 1961 Jul; 9():851-5. PubMed ID: 13694434
    [No Abstract]   [Full Text] [Related]  

  • 10. [Influence of ellagic acid and heparin on coagulation, fibrinolysis and metastasis in traumatized animals (author's transl)].
    Agostino D; Agostino N
    Sangre (Barc); 1980; 25(6):989-98. PubMed ID: 7221832
    [No Abstract]   [Full Text] [Related]  

  • 11. [The in-vitro heparin tolerance test in practice. II. The control of anticoagulant therapy].
    DALLA VOLTA S; FUSARO A
    Prog Med (Napoli); 1961 Apr; 17():223-30. PubMed ID: 13719441
    [No Abstract]   [Full Text] [Related]  

  • 12. [Heparin and fibrinolysis].
    HOLEMANS R; ADAMIS D; HORACE JF
    Experientia; 1962 Aug; 18():377-8. PubMed ID: 14036305
    [No Abstract]   [Full Text] [Related]  

  • 13. [Research on the mechanism of action of pcmaccelerin (factor V, labile factor). III. Inhibition of proaccelerin by heparin].
    GOBBI F; ASCARI E; BARBIERI U
    Prog Med (Napoli); 1961 Nov; 17():767-76. PubMed ID: 13899354
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison of lipoprotein lipase and clotting activity in lymph and plasma after heparin.
    CONNOR WE
    Proc Soc Exp Biol Med; 1961 Feb; 106():378-80. PubMed ID: 13695090
    [No Abstract]   [Full Text] [Related]  

  • 15. Modulation of blood coagulation and fibrinolysis by polyamines in the presence of glycosaminoglycans.
    Homma R; Mase A; Toida T; Kashiwagi K; Igarashi K
    Int J Biochem Cell Biol; 2005 Sep; 37(9):1911-20. PubMed ID: 15936241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activation of fibrinolysis and thrombolysis by polysaccharide sulfuric acid esters (heparin, heparinoid)].
    HALSE T
    Arzneimittelforschung; 1962 Jun; 12():574-82. PubMed ID: 13904008
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coagulation time in subcutaneous heparin treatment].
    von AHN
    Sven Lakartidn; 1959 Dec; 56():3409-16. PubMed ID: 13792141
    [No Abstract]   [Full Text] [Related]  

  • 18. Fibrinolysis. VIII. Comparative study in vitro of the effects of various proteolytic agents on the blood clotting mechanism of human plasma.
    KARACA M; STEFANINI M; MELE RH; MOSSA A; SOARDI F
    J Lab Clin Med; 1962 Jul; 60():117-24. PubMed ID: 14453835
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies on the "hypercoagulable state".
    Galewski K; Izak G; Eyal Z
    Isr J Med Sci; 1965 Jul; 1(4):865. PubMed ID: 5856135
    [No Abstract]   [Full Text] [Related]  

  • 20. [Activation of fibrinolysis in man by a bacterial pyrogen; influence of phenylbutazone and heparin on fibrinolysis, blood coagulation and fever reaction].
    HORDER MH; KICKHOFEN B; WENDT F
    Klin Wochenschr; 1958 Feb; 36(4):164-6. PubMed ID: 13540142
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.